Predicting Treatment Response in Chronic Hepatitis C Patients
Author Information
Author(s): Onomoto Koji, Morimoto Shiho, Kawaguchi Takahisa, Toyoda Hidenori, Tanaka Masami, Kuroda Masahiko, Uno Kazuko, Kumada Takashi, Matsuda Fumihiko, Shimotohno Kunitada, Fujita Takashi, Murakami Yoshiki
Primary Institution: Institute for Viral Research and Graduate School of Bioscience, Kyoto University, Kyoto, Japan
Hypothesis
Dysregulation of the IFN system can lead to poor response to Pegylated Interferon and Ribavirin therapy in chronic hepatitis C.
Conclusion
The study found that IFN system dysregulation before treatment was associated with poor therapy response, and gene expression patterns can predict drug response with high accuracy.
Supporting Evidence
- Five IFN related-genes had significantly higher expression levels in nonresponders compared to normal liver and sustained virological responders.
- The expression pattern of 31 IFN related-genes differed significantly between nonresponders and normal liver.
- Drug response in nonresponders was predicted with 86.1% accuracy using diagonal linear discriminant analysis.
Takeaway
Doctors can look at certain genes in patients to see if they will respond well to hepatitis C treatment, helping them choose the best therapy.
Methodology
The study used microarray analysis to quantify the expression of 237 IFN-related genes in liver biopsy specimens from 87 chronic hepatitis C patients.
Potential Biases
Potential biases may arise from the selection of patients and the specific genetic background of the population studied.
Limitations
The study focused only on patients with HCV genotype 1b, which may limit the generalizability of the findings.
Participant Demographics
The study included 87 chronic hepatitis C patients, primarily of Japanese descent, with a mean age of approximately 60 years.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website